Companies: 10,795·Total market cap: $144.5T
Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc.

COLLNASDAQHealthcare● Active
$33.31
$-0.07(-0.22%)
Market Cap$1.1B
P/E Ratio
52W High$50.787
52W Low$29.08

Collegium Pharmaceutical, Inc. (COLL) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

coll · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 12 Wall Street analysts in the past 3 months

SellBuy

Buy

12 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
8
Hold
3
Sell
1
Strong Sell
0
Total: 12 · Buy rate: 66.7%

12-Month Price Target

High

$60.00

Consensus

$58.00

+73.4% upside

Low

$56.00

Median: $58 · Last Close: $33.44

The Collegium Pharmaceutical, Inc. (COLL) analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month COLL price target is $58.00, representing +73.4% upside from the current price of $33.44.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $58 (73.4%)

Consensus Target

$58.00

73.4% upside

High Target

$60

79.4%

Low Target

$56

67.5%

Current Price

$33.44

as of today

Based on analyst price targets, the COLL stock price prediction for the next 12 months ranges from $56 to $60. The consensus COLL price forecast of $58.00 implies 73.4% upside from the current price of $33.44.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$32.472.90%

1-day model range: $32.3–$32.64. Peak: $32.64 (-2.90%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$40+19.2%
2028$44+31.9%
2029$47+39.5%
2030$48+44.0%
2031+46.5%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

36%7%57%
5Buy
1Neutral
8Sell
RSI (14)48.7Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · COLL · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$32.21BUY
MA 10$32.73BUY
MA 20$33.61SELL
MA 50$33.90SELL
MA 100$38.05SELL
MA 200$39.49SELL
Current $COLL · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$32.84BUY
EMA 10$32.91BUY
EMA 20$33.38BUY
EMA 50$34.66SELL
EMA 100$36.58SELL
EMA 200$37.31SELL
Current $COLL · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-03-20
Maintains
BuyBuy
Needham2026-03-19
Maintains
BuyBuy
Needham2026-02-26
Maintains
BuyBuy
HC Wainwright & Co.2026-01-09
Maintains
BuyBuy
Barclays2026-01-09
Maintains
OverweightOverweight
Needham2026-01-08
Maintains
BuyBuy
Truist Securities2025-11-07
Maintains
BuyBuy
HC Wainwright & Co.2025-11-07
Maintains
BuyBuy
Needham2025-10-28
Maintains
BuyBuy
Piper Sandler2025-05-09
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Collegium Pharmaceutical, Inc. (COLL) stock. Of the recent 65 rating actions, 3 were upgrades and 5 were downgrades. 12 analysts currently cover COLL.

Analyst Recommendation Trends

Buy ratings02↑ +2
Hold ratings101
Sell ratings00

COLL analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$875M

↑ 4.9% YoY

Revenue Next Year

$886M

↑ 1.3% YoY

EPS This Year

$7.72

EPS Next Year

$7.61

↓ 1.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast COLL EPS of $7.72 for the current fiscal year, based on estimates from 3 analysts. The COLL revenue forecast is $875M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The COLL stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus COLL price target is $58.00 (+73.4% upside), with an analyst consensus of Buy.

The COLL short-term stock prediction for tomorrow is $32.47 (-2.90%). The COLL stock price prediction for 2027 estimates an average of $40. The COLL stock prediction for 2030 projects a range of $45–$51.

Collegium Pharmaceutical, Inc. trades on NASDAQ under the ticker COLL. The COLL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

COLL forecast · 8 questions

According to 12 Wall Street analysts, the average 12-month COLL price target is $58.00, with a high forecast of $60.00 and a low of $56.00. The median price target is shown in the chart above when available. This implies +73.4% potential upside from the current price of $33.44.

COLL price targetWhat is COLL price targetCOLL analyst price targetCOLL 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.